Grant Recipients

Ongoing

Marrow Donor Drives

1990 - Ongoing

In collaboration with The New York Blood Center, New York, NY

Pain and Palliative Care Service

1997 - Ongoing

2023/24

Eyton Stein, MD

Eyton Stein, MD

Memorial Sloan Kettering Cancer Center, New York, NY
“A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated with Upregulation of HOX Genes”

Xiaodi Wu, MD, Ph.D

Xiaodi Wu, MD, Ph.D

Memorial Sloan Kettering
Cancer Center, New York, NY
“Elucidating the Molecular Pathogenesis of Acute Myeloid Leukemia with CEBPA Mutation”

2022-2023

Eyton Stein, MD

Eyton Stein, MD

Memorial Sloan Kettering Cancer Center, New York, NY
“A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated with Upregulation of HOX Genes”

Xiaodi Wu, MD, Ph.D

Xiaodi Wu, MD, Ph.D

Memorial Sloan Kettering
Cancer Center, New York, NY
“Elucidating the Molecular Pathogenesis of Acute Myeloid Leukemia with CEBPA Mutation”

Martina Cardillo, Ph.D

Martina Cardillo, Ph.D

North Shore – LIJ Feinstein Institute for Medical Research Manhasset, NY
“CLL’s and ABC’s: Studies of Shared Phenotypic and Functional Features”

Lingbo Zhang, Ph.D

Lingbo Zhang, Ph.D

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
“Targeting Metabolic Vulnerabilities as Novel Therapeutics for Acute Myeloid Leukemia”

Olga Dashevsky, Ph.D

Olga Dashevsky, Ph.D

Dana-Farber Cancer Center, Boston, MA
“CRISPR Studies to Define Response vs. Resistance Mechanisms to Natural Killer Cells for Myeloma/Plasma Cell Leukemia Cells with Defects Conferring T Cell Resistance”

Salime Benbarche, Ph.D

Salime Benbarche, Ph.D

Memorial Sloan Kettering Cancer Center, New York, NY
“A Novel Gene Therapy Approach to Eliminate Spliceosome Mutant Leukemia

2020-2021

Shayne Yin, Ph.D

Shayne Yin, Ph.D

Dana-Farber Cancer Institute
Dissecting the functional effects of mutated IKZF3 in driving Chronic Lymphocytic Leukemia

Angela Savino, Ph.D

Angela Savino, Ph.D

MSKCC

Targeting the dysregulated metabolic program in Acute Myeloid Leukemia

Zaholin Yang, Ph.D

Zaholin Yang, Ph.D

Cold Spring Harbor Lab

Novel synthetic lethality between the Fanconi anemia pathway and ALDH2 in AML
Rukhsana Aslam, MD

Rukhsana Aslam, MD

Feinstein Institute For Medical Research
Role of the IL-17/TH17 in axis in generating a cytolytic immune response against chronic lymphocytic leukemia in B cells.

2018

Ryosuke Shirasaki, MD

Ryosuke Shirasaki, MD

Dana- Farber Cancer Institute
Boston, MA

“CRISPR studies on mechanisms of resistance to pharmacological degraders of proteins driving plasma cell leukemia or other blood cancers”

Henry D. Herce, MD

Henry D. Herce, MD

Dana-Farber Cancer Institute
Boston, MA

“Therapeutic reactivation of apoptosis in leukemia by targeting the control points of bax suppression.”

Rukhsana Aslam,MD

Rukhsana Aslam,MD

Feinstein Institute at Northwell Health
Manhasset, NY

Role of the IL-17/Th17 in axis in generating a cytolytic immune response against chronic lymphoctic leukemia B cells” 
Yiliang Wei, Ph.D.

Yiliang Wei, Ph.D.

Cold Spring Harbor Laboratories
Cold Spring Harbor, NY

“Probing leukemia vulnerabilities in vivo with domain-targeting CRISPR screening”

2017

Ken Morita, MD, PhD

Dana- Farber Cancer Institute
Boston, MA
“Identification of Antileukemic Drugs Using
T-Cell Acute Lymphoblastic Leukemia Zebrafrish Models.”

Florencia Leticia Palacios, PhD

Feinstein Institute at Northwell Health
Manhasset, NY
“Characterization of the Biological Function
of Musashi2 RNA Binding Protein in Chronic Lymphocytic Leukemia”

Friederike Pastore, MD

Memorial Sloan Kettering Cancer Center
New York, NY
“Modeling Novel Translocations in Hematopoetic”
“Malignancies Using CIRPSR/Cas9.”

Yusuke Tarumoto, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Targeting Linked Dependency Between Kinase and Transcription Factor.”

2016

Prabodhika Mallikaratchy, PhD

CUNY-Lehman College
Bronx, NY
“Design and Development of DNA Aptamer Based Immunotherapeutic”

In memory of Muriel Fusfeld

Grant made possible by Caryl Rubenfeld and The Muriel Fusfeld Foundation

Katrien Van Roosbroeck, PhD

University of Texas MD Anderson Cancer Center
Houston, TX
“Role of MicroRNA’s in Aggressive Transformation of Chronic Lymphocytic Leukemia to Richter Syndrome”

Akihide Yoshimi, MD. PhD

Memorial Sloan Kettering Cancer Center
New York, NY
“Understanding the Collaborating Events Essential for IDH-Mutant Leukemogenesis”

Grant is partially funded by Caryl Rubenfeld and The Muriel Fusfeld Foundation

Florencia Leticia Palacios. PhD

Feinstein Institute at Northwell Health
Manhasset, NY
“Characterization of the Biological Function of Musashi2 RNA Binding Protein in Chronic Lymphocytic Leukemia”

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

Yusuke Tarumoto, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Identification of Genetic Dependencies and Therapeutic Targets in AML”

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

2015

Yana Pikman, MD

Dana-Farber Cancer Center
Boston, MA
“Targeting mitochondrial folate metabolism for novel acute myeloid Leukemia therapy”

Olga A. Guryanova, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, NY
“Novel treatment strategies for DNMT3A-mutant high-risk MDS”

Peter K. Gregerson, MD & Kim Stimfendorfer, PhD

North Shore-LIJ Feinstein Institute for Medical Research
Manhasset, NY
“Small Molecules targeting PTPN22-Csk interaction to alter immune signaling thresholds.”

In memory of Muriel Fusfeld

Grant made possible by Caryl Rubenfeld and The Muriel Fusfeld Foundation

Andrea Nicola Mazzarello, PhD

North Shore-LIJ Feinstein Institute for Medical Research
Manhasset, NY
“Immunoglobulin heavy chain isotype effects antibody reactivity and affinity and can lead to unabated B-cell stimulation in CLL”

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

Yusuke Tarumoto, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Investigation of mechanism of epigenetic inhibitor-induced therapeutic activity”

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

2014

Andrea Nicola Mazzarello, PhD

North Shore-LIJ Feinstein Institute for Medical Research
Manhasset, NY
“Immunoglobulin heavy chain isotype effects antibody reactivity and affinity and can lead to unabated B-cell stimulation in CLL”

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

Jon A. Oyer, PhD

Northwestern University
“Consequences of the MMSET E1099K Mutation in Acute Lymphoblastic Leukemia (ALL)”

John Anto Pulikkan, PhD

University of Massachusetts
“Medical School Targeted Therapy for Core Binding Factor Leukemia”

Jae Seok Roe, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Investigating p300-dependent Recruitment
Mechanism of Brd4″

Grant made possible by Walter Kissinger

In memory of Ambassador Felix Schnyder

2013

Gerardo Ferrer, PhD

The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems
Manhasset, NY
“An in vivo analysis of the cellular interaction governing the engraftment and growth of human chronic leukemia B Cells”

The grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In memory of Ambassador Felix Schynder

Koshi Akahane, MD

Dana Farber Cancer Institute
Boston, MA
“Significance of innate resistance to mitochondrial Apoptosis in high-risk T-ALL”

Faith Mercan, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Engineering Peptide-Based Brd4 Bromodomain”
“Inhibitors using Phage Display”

The grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In memory of Ambassador Felix Schnyder

Kim Stimpfendorfer, PhD

The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems
Manhasset, NY
“Study of Characterization of proliferative and
Renewing cell populations in chronic CLL”

The grant was made possible by Caryl Rubenfeld of The Muriel Fusfeld Foundation

In memory of Muriel Fusfeld

2012

Shinpei Kawaoka, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Targeting Bromodomain Proteins in Acute Lymphoblastic Leukemia”

Grant was made possible by Walter Kissinger and The Felix Schnyder Memorial Fund

In memory of Ambassador Felix Schnyder

Rita Simone, PhD

The Feinstein Institute for Medical Research North Shore
Manhasset, NY
“A Novel Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia Suggests a Key Role for T Lymphocytes in the Disease”

Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In memory of Ambassador Felix Schnyder

Andrew Lane, MD, PhD

Dana Farber Cancer Institute
Boston, MA
“Defining Chromosome 21 Loci that Promote Lymphoid Leukemogenesis.”

In memory of Michael J. Lopez and Lauri Strauss

Kim Stimpfendorfer, PhD

The Feinstein Institute for Medical Research North Shore
Manhasset, NY
“B Lymphocyte Kinase (Blk): A Risk Gene for Autoimmunity and T-Cell Leukemia”

Grant was made possible by Caryl Rubenfeld and the Muriel Fusfeld Foundation

In memory of Muriel Fusfeld.

2011

Omar Abdel-Wahab, MD

Memorial Sloan Kettering Cancer Center
New York, NY
“Role of ASXLI mutations in acute myelogenous leukemia”

This Grant was made possible by Mary Jo and John Boler

In memory of Richard J. Giffels, Helen DeGulis and Patricia Winkel

Lyne Khair, PhD

University of Massachusetts Medical School
Worcester, Ma
“Genome Wide DNA Breaks Induced by AID During B Cell Activation”

Kim Stimpfendorfer, PhD

The Feinstein Institute for Medical Research North Shore – LIJ Health Systems
Manhasset, NY

“B lymphocyte Kinase (Blk): a risk gene for autoimmunity and T cell leukemia” 

This grant was made possible by Caryl P. Rubenfeld and The Muriel Fusfeld Foundation. 

In memory of Muriel Fusfeld 

Rita Simone, PhD

The Feinstein Institute for Medical Research North Shore – LIJ Health Systems
Manhasset, NY
“A Novel Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia”
“Suggests a Key Role for T Lymphocytes in the Disease”

This grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In Memory of Ambassador Felix Schnyder

Emma Vernersson Lindahl, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Investigating the Impact of TAp63 on Hematopoietic Malignancies Utilizing
a Novel TAp63-Deficient Mouse Model.”

2010

Davide Bagnara, PhD

The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems
Manhasset, NY
“Development of an Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia” 

This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In Memory of Ambassador Felix Schnyder

Yuchen Chien, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
“Critical Contribution of NF-kB to Chemoresistance of Myc and Bc12 Driven Lymphoma in Mice”

This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund

In Memory of Ambassador Felix Schnyder

Patricia Ernst, PhD

Dartmouth Medical School
Hanover, NH
“Genetic and Biochemical Approaches to Targeting Mixed Lineage Leukemia”

Monica L. Guzman, PhD

Joan & Sanford I. Weill Medical College of Cornell University
New York, NY
“Targeting of Human Acute Myelogenous Leukemia Stem Cells”

Rajesh R. Singh, PhD

University of Texas MD
Anderson Cancer Center
Houston, Texas
“Targeting Sonic Hedgehog Signaling to Overcome Chemoresistance in Diffuse Large B-Cell Lymphoma”

Emily S. Tonorezos, MD, MPH

Sloan Kettering Institute for Cancer Research
New York, NY
“Diet and Insulin in Survivors of Childhood Leukemia”

This Grant was made possible
by MaryJo and John Boler

In Memory of Helen DeGulis, Richard J. Giffels, Donald George Uhlir, and Patricia Winkel.

2009

Ikbel Achour, PhD

2009

University of Illinois at Chicago
Springfield, IL
Mechanisms of Chromosomal Translocation
In B Lymphocytes
This Grant was made possible
by Mary Jo and John Boler
In Memory of Richard J. Giffels

Shih-Shih Chen, PhD

Feinstein Institute for Medical Research
North Shore-LIJ Health Systems
Manhasset, NY
Role of B-cell Antigen Receptor Engagement in Chronic Lymphocytic Leukemia: Survival and Expansion Versus Anergy and Death
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

Ya-Huei Kuo, PhD

Beckman Research Institute of City of Hope
Duarte, CA
Analysis and Targeting of Leukemia Stem Cells in Inv(16)-Associated Acute Myeloid Leukemia
This grant was made possible by Mary Jo and John Boler In Memory of Helen DeGulis

Cornelious Miething, MD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
Study on the Role of PTEN in Tumorigenesis and Development of Chemoresistance in a MiR30-Based Transgene Murine Model of Conditional PEN Inactivation.
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund
In Memory of Ambasador Felix Schnyder

Rushdia Yusuf, MD, MPH

Massachusetts General Hospital
Boston, Mass
The Role of UDP-Glucose in Protection of A Hematopoietic Stem Cells from Chemotherapy
This Grant was made possible by MaryJo and John Boler
In Memory of Patricia WInkel

Camile P. Semighini, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
Use of reversible RNA interference in transgenic mice to study the importance of RB and ATM in tumor
development, maintenance and response to therapy.
Ambassador Felix Schnyder Memorial Grant
In Memory of Ambassador Felix Schnyder

Carlo Calissano, MD

The Feinstein Institute for Medical Research,
North Shore – LIJ Health Systems
Manhasset, NY
Identification and characterization of chronic lymphocytic leukemia B cells and their normal B
lymphocyte counterpart
Ambassador Felix Schnyder Memorial Grant
In Memory of Ambassador Felix Schnyder

James L. LaBelle, M.D., PhD

Dana-Farber Cancer Institute
Boston, MA
Title Dismantling the Apoptotic Blockade of Refractory Leukemia by Pharmacologic Replacement of the Tumor Suppressor BIM
This Grant Made Possible by Muriel Fusfeld Foundation

2008

Filiz Sen, MD

2008

New York University School of Medicine
New York, NY
Title FBN7 Mutations in T Cell ALL
This Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis

Angela Stoddart, PhD

The University of Chicago
Chicago, IL
Determining the Transforming Mechanism of the CLAM-AF10 fusion Protein: Does Defective Endocytosis Synergize with Transcriptional Deregulation?
This Grant Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels

Lili Wang, MD

University of Illinois at Chicago
Chicago, IL
Title Mechanisms of Chromosomal Translocation in B Lymphocytes
This Grant made possible by Mary Jo and John Boler
In Memory of Patricia Winkel

Eleana Levantini, PhD

Beth Israel Deaconess Medical Center
Boston, Mass
Development of transgenic models to mimic human leukemias: the BVR/ABL case
Ford Motor Company Fund and The Johnny Mercer Foundation for their assistance in making this grant possible.

2007

Jan Andreas Burger, MD

2007

M.D. Anderson Cancer Center
Houston, TX
Phosphoinositide 3-Kinases in Chemokine Receptor Signaling in Chronic Lymphocytic Leukemia
Made Possible by Mary Jo and John Boler
In Memory of Helen DeGulis

Javier Pinilla-Ibarz, MD, PhD

H. Lee Moffitt Cancer Center
Tampa, FL
Correlative Immunological Studies of a Pilot Trial With a WTl Analog Peptide Vaccine in
Patients With Myeloid Malignancies
Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels

Monica Buzzai, PhD

Northwestern University Feinberg School of Medicine
Chicago, IL
Cell Survival and Proliferation Pathways Mediated by JAK2 Mutations in Myeloproliferative Disorders (MPD) and Leukemia Made
Possible by Mary Jo and John Boler
In Memory of Patricia Winkel

B. Belinda Ding, PhD

Albert Einstein College of Medicine
Bronx, NY
Mechanism of STAT3 Activation in Diffuse Large B-cell Lymphoma
Made Possible by Ford Motor Company and The Johnny Mercer Foundation
In Memory of Johnny Mercer

Ramiro Garzon, MD

The Ohio State University
Columbus, OH
Role of MicroRNA in the Pathogenesis of Acute Myeloid Leukemia
Made Possible by the Friends of José Carreras International Leukemia Foundation

Rosa Catera, PhD

The Feinstein Institute for Medical Research
North Shore – LIJ Health System
Manhasset, NY
Bacterial Components as Epitopes for B-CLL Antibodies
Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

Timothy S. Pardee, MD, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
Correlative Immunological Studies of a Pilot Trial With a WTl Analog Peptide Vaccine in
In Vitro Array Based Screening for Genes Involved in Chemoresistance and
Sensitivity in Acute Myelogenous Leukemia
Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

2006

Dong Hong Cai, MD, PhD

John Hopkins University
Baltimore, MD
Interaction Between C/EBPa and AP-1 in Myeloid Leukemogenesis
Grant made possible by Mary Jo and John Boler
In memory of Patricia Winkel

Scott Cameron, MD, PhD

U T Southwestern Medical Center, Dallas, TX
Mechanism of Programmed Cell Death in
MI1- positive Leukemia
Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis

Nobuharu Fujii, MD, PhD

Fred Hutchinson Cancer Research Center, Seattle,WA
Transcription Factors in Hematopoietic Stem Cells As Targets For Leukemia Immunotherapy
Grant Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels

Ann Jakubowski, MD, PhD

Memorial Sloan Kettering Cancer Center
New York NY
Clinical and Laboratory Studies of Keratinocyte Growth Factor to Facilitate Immune Reconstitution in Patients Undergoing an Allergenic Stem Cell Transplant Grant made possible by Alvin Marks In Memory of Elaine Marks

Hanno Hock, MD, PhD

Massachusetts General Hospital, Boston, MA
Re-creation of Leukemogenic TEL-AML1
Fusion in Embryonic Hematopoiesis
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

H. Daniel Lacorazza, PhD, PI

Baylor College of Medicine
Dallas, TX
Regulation of ELF-4 Gene Expression in Leukemic Cells
Grant made possible by Ford Motor Company and by the Johnny Mercer Foundation
In Memory of Johnny Merce

Brian McCarthy, PhD

North Shore / Long Island Jewish Health System Manhasset, NY
Analysis of Patient Parameters Related to the
B-Cell Receptors to Chronic Lymphocytic
Leukemias
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Johannes Zuber, MD

Cold Spring Harbor Labaoratory, Cold Spring Harbor,NY
In-Vivo Analysis of Key Genes and Mechanisms
of Resistance in the Therapy of Active Myeloid
Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2005

Deepa Trivedi, MD

2005

Memorial Sloan Kettering Cancer Center,NY, NY
Generation of Cytomegalovirus (CMV) Specific
T- Lymphocytes using Protein Spanning Pools of Pentadecapeptides for Adoptive Immuno Therapy
Grant made possible by Mary Jo and John Boler
In Memory of Patricia Winkel

Farshid Dayyani, MD

Massachusetts General Hospital
Boston, MA
The Role of Groucho Family Co-Repressors TLE1 and TLE4 in Hematopoiesis and Leukemogenesis
Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis

Manabu Shimoyama, MD, PhD

Mount Sinai School of Medicine, NY, NY
The Importance of the SET Domain and Histone
Methylation in Leukemia and Other Hematological
Malignancies
Grant made possible by Mary Jo and John Boler
In Memory of Donald George Uhlir, DVM

Florence Bernardin Fried, PhD

Johns Hopkins Hospital, Baltimore, MD
Regulation of Proliferation by the AML 1
Leukemia Oncoprotein
Grant made possible by Ford Motor Company

Daniel Ditzel Santos, MD

Dana Farber Cancer Center
Boston, MA
Targeting Mast Cells and Mast Cell Interactions in the Treatment of Waldenstrom’s Macroglobulinemia
Grant made possible by The Muriel Fusfeld Foundation In Memory of Muriel Fusfeld

Claudia S. Huettner, PhD

Blood Center Institute of Blood Center of Wisconsin Milwaukee, WI
Role of Bcl-x Leukemogenesis by BCR/ABL
Grant made possible by The Johnny Mercer Foundation In Memory of Johnny Mercer

Enrique Cepero, PhD

Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY
The Role of Caspases In Leukemia Suppression and Chemotherapy Response, In Vivo
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Santanu Paul, PhD

North Shore-Long Island Jewish Health Systems Manhasset, NY
Telomere Reconstruction in Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2004

Michelle A. Kelliher, PhD

2004

University of Massachusetts Medical School
Department of Cancer Biology,
Worchester, MA

Mechanism(s) of TAL-1/SCL-Medicated
Leukemogenesis
Grant made possible by the Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

Eyal Attar, MD

Massachusetts General Hospital, Boston, MA
Targeting Quiescent Leukemia Stem Cells via
Proteasome Inhibition
Grant made possible by Ford Motor Company

Anthony G. Brickner, PhD

The University of Pittsburgh
Pittsburgh, PA
Identification of Graft-vs.-Leukemia Associated Human Minor Histocompatibility Antigens
Grant made possible by The Johnny Mercer Foundation
In Memory of Johnny Mercer

Bradley Messmer, PhD

North Shore – Long Island Jewish
Research Institute, Manhasset, NY

Characterizing the Antigens Receptors Used by
B-CLL Cells
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Clare Louise Scott, PhD

Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Identification of Genes Important in Drug-Induced Senescence in a Murine Eu-myc Lymphoma Model
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2003

Danillo Perrotti, MD, PhD

James Cancer Hospital and Richard J. Solove
Research Institute, Ohio State University
Columbus, OH

Research initiated at Thomas Jefferson University,
Philadelphia, PA
Role of BCR/ABL Oncogene in Suppression
of Neutrophilic Differentiation
Grant made possible by The Johnny Mercer Foundation
In Memory of Johnny Mercer

William Tse, MD

Case Western Reserve University School of Medicine, Cleveland, OH
Research Initiated at Fred Hutchinson
Cancer Research Center Clinical Significance of AF1q Gene in Myeloid and Lymphoid Leukemia
Grant made possible by Ford Motor Company

Loren D. Walensky, MD, PhD

Dana Farber Cancer Institute
Boston, MA
Targeting Apoptosis in Leukemia by Chemical Design
Grant made possible by Cell Therapeutics

Artur Slupianek, PhD

College of Science and Technology Center for Biotechnology, Temple University, Philadelphia, PA
Role of Rad51 Family Members in Drug Resistance Induced by BCR/ABL
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

Emilia Albesiano, PhD

North Shore – Long Island Jewish Research Institute, Manhasset, NY
Identification of Activation-Induction Cytidine
Deaminase Expression in B Cell Type Chronic
Lymphocytic Leukemia Cells
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Susan Kambhampti, MD

Northwestern School of Medicine
Northwestern University, Chicago, IL

Role of Protein Kinase C-Delta in the Induction of All-Trans-Retinoic Acid Responses in APL Cells
Courtesy of the Madoff Family

Michael Hemann, PhD

Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY

Improving the Characterization and Treatment of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Nicholas Chiorazzi, MD in association with Charles C. Chu, PhD

North Shore-Long Island Jewish
Research Institute, Manhasset, NY

Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B Lymphocytes from Patients with Systematic Lupus Erythematosus
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

2002

Benjamin Boettner, PhD

2002

Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Identification and Characterization of Genes
Regulated by BCR-ABL, The Causative Agent of
Chronic Myelogenous Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Kevin D. Bunting, PhD

American Red Cross Holland Laboratory, Rockville,MD
Functional Characterization of the Role of the Novel Mixed Lineage Leukemia-Associated AFIq Gene Product in Myeloid Leukemia Cell Differentiation
Grant Made Possible by The Johnny Mercer Foundstion
In Memory of Johnny Mercer
Nicholas Chiorazzi, MD in association with

Charles C. Chu, PhD

Laboratory of Molecular Immunology/Gene
Activation, North Shore-Long Island Jewish
Research Institute, Manhasset, NY

Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B
Lymphocytes from Patients with Systematic Lupus
Erythematosus
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

Yih-Pai Chu, PhD

North Shore-Long Island Jewish
Research Institute, Manhasset, NY

The Role of Tumor Necrosis Factor-alpha in the
Proliferation and Survival of the Leukemic Cells in B Cell Type Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Dilip Patel, MD

Long Island Jewish Medical Center,New Hyde Park, NY
Initiation of Study of Familial Chronic
Lymphocytic Leukemia (CLL) Starting with a
Systematic Survey of CLL Patients Who Have a
First-Degree Relative with CLL or a Related
Lymphoid Disorder
In Honor of Kanti R. Rai, MD

Constantine Mitsiades, MD

Dana Farber Cancer Institute, Boston, MA
Biologically Based Therapeutic Strategies to
Enhance the Activity of TRIAL/Apo21 Against
Leukemias, Lymphomas and Myeloma
Grant made possible by Ford Motor Company

Joseph Schwartz, MD

Memorial Sloan Kettering Cancer Center,NY, NY
Leukemia Immunotherapeutic Approaches Using the WT-1 Antigen as a Target
In Memory of Michael J. Lopez

Richard D. Huhn, MD

Coriell Institute for Medical Research, Camden, NJ
Studies of the Cellular Basis of Delayed Platelet
Engraftment Following Transplantation of Culture Expanded Cord Blood Stem/Progenitor Cells
In Memory of Michael Lopez
Grant Made Possible by The Muriel Fusfeld Fundation

Jeffrey M. Lipton, MD, PhD

Schneider Children’s Hospital,New Hyde Park, NY
Financial Support for an Additional Childlife Specialist

2001

David M. Loeb, MD, PhD

2001

Division of Pediatric Oncology Johns Hopkins University, Baltimore, MD
The Role of WTI in Resistant AMI In Memory of Michael J. Lopez

Nicholas Mitsiades, MD

Dana Farber Cancer Institute, Boston, MA
Biotherapy of B-Cell Malignancies by Trial
Medicated Apoptosis
Grant made possible by the Johnny Mercer Foundation
In Memory of Johnny Mercer

Andromachi Scaradavou, MD

New York Blood Center Lindsay K. Kimball Research Institute Laboratory of Immunogenetics, New York, NY
Material Microchimerism in Unrelated Placental Cord Blood Recipients Grant made possible by Ford Motor Company

Jordan Fridman, PhD

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Identification and Analysis of Drug Resistance
Mechanisms in Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Davorka Messmer, PhD

North Shore University Hospital,
Manhasset, NY

Generation of a CTL Response to B-CLL Cells
Using Tumor Antigen-Pulsed Dendritic Cells
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2000

Dr. Raymond Comenzo, MD

2000

Memorial Sloan Kettering Cancer Center,NY, NY
Study of the Use of Infusions of Stem Cells from Patients Following High-dose Chemotherapy or Radiation Therapy as an Alternative to Allogeneic Bone Marrow Transplant
In Memory of Louise Scheinberg

Erica Lerma, MD

Sidney Kimmel Cancer Center, San Diego, CA
Identification and Analysis of Drug Resistance
Molecular Therapy of CML
In Memory of Michael J. Lopez

Jonathan Finlay, MB, ChB

New York University School of Medicine
Stephen D. Hassenfeld Center for Children’s Cancer and Blood Disorders
New York University Medical Center, NY, NY

Topotecan Phase I Clinical Trial for Leukemic,
Lymphomatous and Other Pediatric Neoplastic
Leptomeningeal Malignancies
In Honor of Adam Schwartz

Naoto Hirose, MD

North Shore University Hospital,Manhasset, NY
Autoreactivity Maturation Stage in Gene
Expression in the Immunobiology and Clinical
Outcome of Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

B. Hilda Ye, PhD

Albert Einstein College of Medicine Cancer Center, Bronx, NY
Role of the BCL-6 Oncogene in Lymphoma
Cell Lines

Scott Lowe, PhD

Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Molecular Basis of Drug Resistance in a
Mouse Model of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Nicholas Chiorazzi, MD and Charles C. Chu, PhD

North Shore University Hospital,Manhasset, NY
Determination of Human Fig 1
Polymorphisms in SLE Patients
Grant made possible by The Muriel Fusfeld Foundaton
In memory of Muriel Fusfeld

1999

Dominique Bonnet, PhD

1999

Coriell Institute for Medical Research, Camden, NJ
Characterization of the Cell Cycle Status of
Acute Myeloid Stem Cells Using
NOD/SCID-Leukemia Model
In memory of Michael J. Lopez

Scott Dessain, MD, PhD

Thomas Jefferson University, Philadelphia, PA
The Telomerase Gene in Tumorigenesis and Chronic Myelogenous Leukemia Research undertaken at Dana Farber/Partners Cancer Care Whitehead Institute for Biomedical Research, Boston, MA

Hao-peng Xu Duffy, PhD

Stonybrook University, Stonybrook, NY
Study of Multidrug Resistant Phenotype in
Leukemia

North Shore University Hospital, Manhasset, NY

Research undertaken at Department of Molecular Oncology
Grant made possible by the Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Nicholas K. Tonks, PhD

Cold Spring Harbor Laboratory,Cold Spring Harbor,NY
Investigating Molecular Links to Chronic
Myelogenous Leukemia (CML)
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

1998

Arup Chakraborty, PhD

1998

Children’s Nutrition Research Center, Houston, TX
Role of Stat3 in G-CSF-mediated Myeloid
Differentiation
In memory of Michael J. Lopez

Hao-peng Xu Duffy, PhD

Stonybrook University
Stonybrook, NY
Continuation of 1997 Grant Research undertaken at Department of Molecular Oncology North Shore University Hospital, Manhasset, NY
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Steven P. Treon, MD, PhD

Massachusetts General Hospital Dana Farber Cancer Institute Harvard Medical School, Boston, MA
Study of Muc-1 and Multiple Myeloma

Nicholas Tonks, PhD

Cold Spring Harbor Laboratory,Cold Spring Harbor, NY
Continuation of 1997 Grant
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

1997

Hao-peng Xu Duffy, MD, PhD

1997

Stonybrook University, Stonybrook, NY
Study of Genomic Lesions in Chronic
Lymphocytic Leukemia Research undertaken at Department of Molecular Oncology
North Shore University Hospital,
Manhasset, NY

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Kenichi Takeshita, MD

Hematology Division, Department of Medicine
New York University Medical Center, NY, NY

Homeobox Gene Expression in Human Myeloid
Leukemia
In memory of Michael J. Lopez

Michael Tomasson, MD

1997

Washington University School of Medicine
St. Louis, MO

Murine Models of Tyrosine Kinase Fusion Protein Mediated Leukemogenesis

Nicholas K. Tonks, PhD

Cold Spring Harbor Laboratory,Cold Spring Harbor,NY
Protein Tyrosine Phosphatases and Chronic
Myelogenous Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

1996

Michael W. Schuster, MD

New York Weill Cornell Center, New York, NY
Research Undertaken at North Shore University Hospital, Manhasset, NY

Purging Bone Marrow With Magnetic Beads
in Autologous BHT
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Naoko Tanese, PhD

Department of Microbiology NYU Medical Center, New York, NY
Analysis of Proteins Involved in Transcriptions and Oncogenesis
In memory of Michael J. Lopez

Nicholas K. Tonks, PhD

Cold Spring Harbor Laboratory
Cold Spring Harbor, NY
Pattern That Leads to Dysfunctional Maturation of Hematopoetic Stem Cells in CML
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Patricia Levy Yeyati, PhD

Brookdale Center, Mt. Sinai Hospital, NY, NY
Research undertaken at Mt. Sinai School of Medicine, NY,NY
Identification of Genes Regulated by the
Promyelocitic Leukemia Zinc Finger Protein

1995

Michael Gilman, PhD

1995

Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Controlling Cell Growth in Lymphoid CLL
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Elizabeth A. McGuire, MD

University of Pittsburgh Medical Center Institute, Pittsburgh, PA
Functional Characterization of Ttgl, a LIM Domain of Oncogene in T-ALL

Michael W. Schuster, MD

1996

New York Weill Cornell Center, NY, NY
Research Undertaken at North Shore
University Hospital, Manhasset, NY

Extended Research was Performed on a Class of Drugs That Shuts Down a Leukemia Cell’s
Resistance to Cancer Killing Chemotherapy
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

Richard Steinman, MD, PhD

University of Pittsburgh Medical Center
Cancer Institute, Pittsburgh, PA

The Role of p21 (WAF-1) to Hematopoietic Differential

1994

Children’s Center for Cancer and Blood Disorders New York University Medical Center, NY
These funds were applied in part to support
psycho-social services rendered to children with leukemia and other forms of cancer and their families, as well as to enable underinsured or uninsured children to receive optimal medical care at the Center.
In honor of Adam Schwartz

Ursula Matulonis, MD

Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Therapies to Block the Interaction of BCR-ABL with Proteins in CML Cell Growth

David A. Scheinberg, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, NY
Monoclonal Antibodies in Patients with ‘APL’

1993

Children’s Center for Cancer and Blood Disorders New York University Medical Center, NY
These funds were applied in part to support
psycho-social services rendered to children with leukemia and other forms of cancer and their families, as well as to enable underinsured or uninsured children to receive optimal medical care at the Center.
In honor of Adam Schwartz

Florence Ajchenbaum, MD

Dana-Farber Cancer Institute, Boston, MA
Cancer Associated Genes’ Ability to Control Growth and Their Role in the Development of Leukemias

Steven Nimer, MD

Memorial Sloan Kettering Center, NY, NY
Molecular Targets to Develop Novel and Specific Methods of Diagnosing and Treating Acute Leukemia

1992

Verena Bier, MD

1992

University of Heidelberg, Visiting Fogarty Fellow, National Cancer Institute,Bethesda, MD
Gene Development and Cell Growth as They
Relate to the Formation of Leukemia

Kanti R. Rai, MD

Long Island Jewish Medical Center,
New Hyde Park, NY

The Study of Chronic Lymphocytic Leukemia,
Including Evaluation of New Drugs

1991

Robert J. Fallon, MD, PhD

1991

Riley Children’s Hospital, Indiana University
School of Medicine, Indianapolis, IN

Cell Related Abnormalities Occurring in
Early Stages of Cancer
Research undertaken at Pediatric Hematology/Oncology
and Stem Cell Transplants, Cardinal Glennon
Children’s Hospital, St. Louis School of Medicine, St. Louis, MO

Gene Development and Cell Growth as They Relate to the Formation of Leukemia
Long Island Jewish Medical Center,
New Hyde Park, NY
Evaluation of New Drugs in CLL Continuation
of 1990 Grant

1990

Loren Walensky, MD

1990

Resident, Children’s Hospital Medical Center Boston, MA
Study undertaken at Princeton University
mentored by Professor Taylor – Research as a Summer
Fellow in Chemotherapeutic Development

Sujata Rao, MD

Fred Hutchinson Cancer Center, Seattle, WA
Research undertaken at Memorial Sloan Kettering Cancer Center, NY, NY

Purging in Bone Marrow Transplantation